Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 574 of 1,261

  1. US 9932543

    Bacterial spore compositions for industrial uses

    Envera, LLC · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  2. US 9932387

    Compositions and methods for immunomodulation in an organism

    UNIVERSITY OF CONNECTICUT · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  3. US 9932398

    Restricted immunoglobulin heavy chain mice

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  4. US 9932391

    Proteins with repetitive bacterial-IG-like (Big) domains present in Leptospira species

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  5. US 9932325

    Compounds, compositions, and methods

    DENALI THERAPEUTICS INC. · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  6. US 9932383

    Cold- and menthol-sensitive receptor (CMR1)

    The Regents of the University of California · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  7. US 9932372

    Designer peptide-based PCV2 vaccine

    United Biomedical, Inc. · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  8. US 9931418

    Compositions for the delivery of RNA and drugs into cells

    Northwestern University · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  9. US 9931414

    Pyrrolobenzodiazepine-antibody conjugates

    ADC THERAPEUTICS SA · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  10. US 9931419

    Methods and compositions for liposomal formulation of antigens and uses thereof

    The Regents of the University of California · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  11. US 9931393

    Immunogenic JC polyomavirus compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  12. US 9931349

    Steroid hormone pharmaceutical composition

    Compass Therapeutics LLC · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  13. US 9931340

    Pyridazinone compounds and their use as DAAO inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  14. US 9931377

    Cell expressing complexes of IL-15 and IL-15Ralpha

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  15. US 9933434

    Therapeutic antibodies against ROR-1 protein and methods for use of same

    The Regents of the University of California · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  16. US 9931415

    Pyrrolobenzodiazepine-antibody conjugates

    ADC THERAPEUTICS SA · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  17. US 9931412

    Targeted theranostics

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  18. US 9932406

    Human monoclonal antibodies specific for glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  19. US 9932564

    Recombinant isfahan viral vectors

    The Board of Regents of the University of Texas System · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  20. US 9931334

    Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  21. US 9925254

    Synthetic antigen constructs against Campylobacter jejuni

    United States of America as represented by the Secretary of the Air Force · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted

  22. US 9926380

    Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease

    The Board of Regents of the University of Texas System · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted

  23. US 9926315

    Triazolopyridine compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted

  24. US 9926272

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.